Last reviewed · How we verify
Lidocaine injection tourniquet
At a glance
| Generic name | Lidocaine injection tourniquet |
|---|---|
| Also known as | Xylocaine, Tourniquet |
| Sponsor | Wake Forest University Health Sciences |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Using Lidocaine or Dexmedetomidine to Help Control Blood Pressure Spikes From a Tourniquet During Knee Surgery (PHASE2)
- Supraclavicular Block vs Bier's Block for Forearm Trauma Surgery (NA)
- Comparison of Bier Block and Lidocaine-Propofol Mixture for Prevention of Propofol Injection Pain (NA)
- Comparative Efficacy of IV Parecoxib vs Lidocaine in Reducing Propofol Injection Pain (NA)
- Wide-Awake Local Anesthesia No Tourniquet (WALANT) With Versus Without Hyaluronidase for Hand Surgery (PHASE2, PHASE3)
- WALANT Versus Axillary Brachial Plexus Block in Carpal Tunnel Release (NA)
- A Comparative Study Between Arm Intravenous Regional Anesthesia Versus Forearm Intravenous Regional Anesthesia in Patients Undergoing Hand and Wrist Surgery (NA)
- Safety and Efficacy of Wide Awake Local Anesthesia no Tourniquet Technique (WALANT) in Ankle Removal of Implant Surgery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lidocaine injection tourniquet CI brief — competitive landscape report
- Lidocaine injection tourniquet updates RSS · CI watch RSS
- Wake Forest University Health Sciences portfolio CI